Heron Therapeutics (HRTX) Q4 2025 Earnings

4NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.1
-0.06
-0.02
0.02

Details

Expected EPS
-0.015
Actual EPS
-0.1
Surprise EPS
-0.09
Surprise Percent
+566.67%

Description

Heron Therapeutics (HRTX) has reported earnings of -0.1 per share for Q4 2025.

0 Comments

Share your thoughts